ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.616,46
-0,03%
S&P 500
5.505,00
-0,71%
US Dollar vs BRL
5,6001
0,00%
Bitcoin
67.342,10
0,25%
Brent Oil
81,875
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Exscientia PLC (EXAI)

  7. Exscientia PLC (EXAI) Notícias

EXAI

Exscientia (EXAI)

Exscientia PLC
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:EXAI
DataHoraFonteTítuloCódigoCompanhia
18/07/202413:36Business WireExscientia erwirbt volle Rechte an potenziellem CDK7-Inhibitor der Spitzenklasse vor der Veröffentlichung von Phase-1-Dosis-EskalationsdatenNASDAQ:EXAIExscientia PLC
18/07/202411:20Business WireExscientia acquiert les droits complets d’un inhibiteur potentiel de CDK7, le meilleur de sa catégorie, avant la publication des données de dose croissante de phase 1NASDAQ:EXAIExscientia PLC
18/07/202408:24Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EXAIExscientia PLC
18/07/202408:00Business WireExscientia Acquires Full Rights to Potential Best-in-Class CDK7 Inhibitor Ahead of Phase 1 Dose Escalation Data ReadoutNASDAQ:EXAIExscientia PLC
10/07/202418:44Business WireExscientia lance une plateforme AWS optimisée par l'IA pour promouvoir la découverte de médicamentsNASDAQ:EXAIExscientia PLC
10/07/202416:13Business WireExscientia bringt KI-gestützte AWS-Plattform zur Verbesserung der Arzneimittelforschung auf den MarktNASDAQ:EXAIExscientia PLC
10/07/202408:00Business WireExscientia Launches AWS AI-powered Platform to Advance Drug DiscoveryNASDAQ:EXAIExscientia PLC
25/06/202406:45PR Newswire (US)EXAI LAWSUIT ALERT: The Gross Law Firm Notifies Exscientia plc Investors of a Class Action Lawsuit and Upcoming DeadlineNASDAQ:EXAIExscientia PLC
20/06/202406:45PR Newswire (US)Exscientia plc Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before June 25, 2024 to Discuss Your Rights - EXAINASDAQ:EXAIExscientia PLC
17/06/202406:45PR Newswire (US)Shareholders that lost money on Exscientia plc(EXAI) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreNASDAQ:EXAIExscientia PLC
10/06/202406:45PR Newswire (US)June 25, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against EXAINASDAQ:EXAIExscientia PLC
06/06/202417:16Business WireExscientia ernennt neue Führungskräfte zur Stärkung der Auswirkungen integrierter Technologien und um den Schwerpunkt auf klinische Entwicklungskompetenz in der Onkologie zu richtenNASDAQ:EXAIExscientia PLC
06/06/202416:49Business WireExscientia nomme de nouveaux dirigeants pour accentuer l'impact des technologies intégrées et recentrer l'expertise en développement clinique sur l'oncologieNASDAQ:EXAIExscientia PLC
06/06/202408:00Business WireExscientia Appoints New Leaders to Strengthen the Impact of Integrated Technologies and Focus Clinical Development Expertise in OncologyNASDAQ:EXAIExscientia PLC
05/06/202406:45PR Newswire (US)Shareholders that lost money on Exscientia plc(EXAI) should contact The Gross Law Firm about pending Class Action - EXAINASDAQ:EXAIExscientia PLC
30/05/202415:30Business WireExscientia participera à des conférences d'investisseurs au mois de juinNASDAQ:EXAIExscientia PLC
30/05/202414:58Business WireExscientia präsentiert sich auf kommenden Investorenkonferenzen im JuniNASDAQ:EXAIExscientia PLC
30/05/202408:00Business WireExscientia to Present at Upcoming Investor Conferences in JuneNASDAQ:EXAIExscientia PLC
29/05/202406:45PR Newswire (US)Exscientia plc Sued for Securities Law Violations - Contact The Gross Law Firm Before June 25, 2024 to Discuss Your Rights - EXAINASDAQ:EXAIExscientia PLC
21/05/202408:00Business WireExscientia Business Update for First Quarter 2024NASDAQ:EXAIExscientia PLC
21/05/202406:45PR Newswire (US)Shareholders of Exscientia plc Should Contact The Gross Law Firm Before June 25, 2024 to Discuss Your Rights - EXAINASDAQ:EXAIExscientia PLC
14/05/202416:52Business WireExscientia legt am 21. Mai 2024 das Geschäftsergebnis für das erste Quartal 2024 vorNASDAQ:EXAIExscientia PLC
14/05/202412:13Business WireExscientia publiera ses résultats financiers du premier trimestre 2024 le 21 mai 2024NASDAQ:EXAIExscientia PLC
14/05/202408:00Business WireExscientia to Report First Quarter 2024 Financial Results on May 21, 2024NASDAQ:EXAIExscientia PLC
07/05/202406:45PR Newswire (US)Exscientia plc Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before June 25, 2024 to Discuss Your Rights - EXAINASDAQ:EXAIExscientia PLC
03/05/202414:27PR Newswire (US)Investors in Exscientia plc Should Contact The Gross Law Firm Before June 25, 2024 to Discuss Your Rights - EXAINASDAQ:EXAIExscientia PLC
21/03/202408:26IH Market NewsU.S. Index Futures Rise as Fed’s Dovish Outlook Spurs Positive Investor Sentiment; Oil Prices See Minor DeclinesNASDAQ:EXAIExscientia PLC
21/03/202408:00Business WireExscientia Business and Financial Update for the Full Year 2023NASDAQ:EXAIExscientia PLC
14/03/202412:29Business WireExscientia présentera ses résultats financiers pour l’année 2023 le 21 mars 2024NASDAQ:EXAIExscientia PLC
14/03/202412:29Business WireExscientia berichtet am 21. März 2024 über die Finanzergebnisse für das Gesamtjahr 2023NASDAQ:EXAIExscientia PLC
 Apresentando as notícias mais relevantes sobre:NASDAQ:EXAI

Seu Histórico Recente

BIT
UB3ZDK
Unicredit Bank
BIT
UC8YKA
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados